Irrespective of whether mice were treated with the depletion antibody or not, the triple combination therapy was also shown to significantly reduce immunosuppressive populations in the tumor, such as the CD244.2+ immunoregulatory receptor, PDL1+ immune checkpoint, and F4/80+ tumor-associated macrophages. Here, CD274 is linked to neoplasm.